Trial NCT00015847

View at ClinicalTrials.gov 
Org. Study IDs: CDR0000068443
Secondary IDs: NCI-2794 OHSU-409 OHSU-6263 OHSU-HEM-00072-LX

Last trial update was posted on 2012-08-20

MeSH Interventions

Imatinib Mesylate Interferon-alpha Interferons

MeSH Conditions

Leukemia Leukemia, Myelogenous, Chronic, BCR-ABL Positive Leukemia, Myeloid

Other Conditions


Stopping Reasons

N/A

Limitations And Caveats

Early termination; 12 month follow-up was not carried out.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID